SCHEMBL7714367

SCHEMBL7714367

NC(=O)CCC(=O)N1CCN(c2nc(N)ncc2Oc2ccc(Cl)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 2/20 0.48
POLB P06746 2/20 0.42
HPGD P15428 4/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 2/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CCNC P24863 2/20 0.39
CDK8 P49336 2/20 0.39
ME2 P23368 1/20 0.39
ME1 P48163 1/20 0.39
ME3 Q16798 1/20 0.39
CCNT1 O60563 1/20 0.39
CDK9 P50750 1/20 0.39
LMNA P02545 2/20 0.39
MAPK1 P28482 1/20 0.39
USP2 O75604 1/20 0.39
ENPP2 Q13822 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7712411 0.92 PI4KB (0.48) PI4KBPOLBHPGDKMT2AMEN1
SCHEMBL7711739 0.90 PI4KB (0.48) PI4KBPOLBHPGDKMT2AMEN1
SCHEMBL7712462 0.86 PI4KB (0.53) PI4KBPOLBHPGDKMT2AMEN1
SCHEMBL7714374 0.84 PI4KB (0.58) PI4KBPOLBHPGDKMT2AMEN1
SCHEMBL7708563 0.84 PI4KB (0.46) PI4KBHPGDALDH1A1CCNCCDK8
SCHEMBL7714261 0.83 MAPT (0.50) PI4KBPOLBHPGDKMT2AMEN1
SCHEMBL7714727 0.81 ALDH1A1 (0.51) PI4KBKMT2AMEN1ALDH1A1NPSR1
SCHEMBL7714733 0.81 PDGFRB (0.43) PI4KBCCNCCDK8CCNT1CDK9
SCHEMBL7714584 0.80 TRPA1 (0.55) PI4KBHPGDALDH1A1RAB9AUSP2
SCHEMBL7708430 0.79 CYP3A4 (0.43) POLBHPGDRAB9AHTTCCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed